AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PERAMPANEL

12 registrations across 3 African markets— 12 active

Markets with PERAMPANEL

Recent registrations

Brand / ProductMarketHolderStatusExpires
FYCOMPA 4MG
TABLET, COATED; ORAL
🇿🇼ZimbabweEISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,activeApr 2031
FYCOMPA 2MG
TABLET, COATED; ORAL
🇿🇼ZimbabweEISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,activeApr 2031
FYCOMPA 4 mg🇿🇦South AfricaEisai PharmaceuticalsactiveJan 1900
FYCOMPA 6 mg🇿🇦South AfricaEisai PharmaceuticalsactiveJan 1900
FYCOMPA 12 mg🇿🇦South AfricaEisai PharmaceuticalsactiveJan 1900
FYCOMPA 2 mg🇿🇦South AfricaEisai PharmaceuticalsactiveJan 1900
FYCOMPA 8 mg🇿🇦South AfricaEisai PharmaceuticalsactiveJan 1900
FYCOMPA 10 mg🇿🇦South AfricaEisai PharmaceuticalsactiveJan 1900
FYCOMPA 4 mg
Film Coated Tablet
🇹🇿TanzaniaEisai Pharmaceuticals Africa (Pty) Ltdactive
FYCOMPA 6 mg
Film Coated Tablet
🇹🇿TanzaniaEisai Pharmaceuticals Africa (Pty) Ltdactive
FYCOMPA 2 mg
Tablet, Film-coated
🇹🇿TanzaniaEisai Pharmaceuticals Africa (Pty) Ltdactive
FYCOMPA 8 mg
Film Coated Tablet
🇹🇿TanzaniaEisai Pharmaceuticals Africa (Pty) Ltdactive

PERAMPANEL in Africa — Regulatory Overview

PERAMPANEL is registered across 3 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tanzania, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.